Theodore Alan Huizenga, CAO of Ultragenyx Pharmaceutical RARE, has filed 0 purchases and 13 sales on the open market. Over the past 12 months that comes to a net sale of $40.1K. The latest trade was on 04/22.

TH

TH

Theodore Alan Huizenga

SVP, Chief Accounting Officer

Company

Ultragenyx Pharmaceutical RARE

First filing

23/03/02

Trades

39 trades

Buys / sales

0 / 13

12-month net buying

−$40.1K

Last trade

04/22

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Ultragenyx PharmaceuticalRARE	Open-market sale	03/02	03/03	1,632 sh	$22.80	$37,209.6	−3.2%
Ultragenyx PharmaceuticalRARE	Open-market sale	25/12/29	25/12/30	85 sh	$34.38	$2,922.3	−0.2%
Ultragenyx PharmaceuticalRARE	Open-market sale	25/09/18	25/09/19	64 sh	$29.17	$1,866.88	−0.1%
Ultragenyx PharmaceuticalRARE	Open-market sale	25/09/05	25/09/08	84 sh	$31.39	$2,636.76	−0.2%
Ultragenyx PharmaceuticalRARE	Open-market sale	25/03/03	25/03/04	967 sh	$42.10	$40,710.7	−1.9%
Ultragenyx PharmaceuticalRARE	Open-market sale	24/09/03	24/09/05	91 sh	$56.19	$5,113.29	−0.2%
Ultragenyx PharmaceuticalRARE	Open-market sale	24/03/01	24/03/05	341 sh	$53.76	$18,332.16	−0.8%
Ultragenyx PharmaceuticalRARE	Open-market sale	23/09/07	23/09/11	2,163 sh2 trades	$40.80avg.	$88,249.42	−8.4%
Ultragenyx PharmaceuticalRARE	Open-market sale	23/09/01	23/09/06	970 sh2 trades	$37.15avg.	$36,032.33	−3.9%
Ultragenyx PharmaceuticalRARE	Open-market sale	23/03/01	23/03/03	100 sh	$45.65	$4,565	−0.4%
Ultragenyx PharmaceuticalRARE	Open-market sale	23/02/28	23/03/02	639 sh	$43.40	$27,732.6	−3.9%